Provivi

About:

Provivi develops biopesticides for agriculture, commercial, household, and public health pest management.

Website: http://provivi.com/

Twitter/X: Provivitm

Top Investors: Temasek Holdings, National Science Foundation, Bill & Melinda Gates Foundation, Aliment Capital, Vivo Capital

Description:

Provivi is developing biopesticides for agriculture, commercial, household, and public health pest management. It has a world-class team of founders, scientists, and advisors with significant experience in biotechnology (including biocatalysis), the fine chemicals industry, and, in particular, the agchem industry. It pursues disruptive opportunities enabled by breakthrough biological processes for making supply-limited products that are efficacious, safe, and environmentally benign. Provivi was founded in 2013 based on biocatalysis technology developed at the California Institute of Technology (Caltech) which has since become a licensor, shareholder, and research collaborator. It is based in Santa Monica, California.

Total Funding Amount:

$192M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Santa Monica, California, United States

Founded Date:

2013-01-01

Contact Email:

info(AT)provivi.com

Founders:

Frances Arnold, Pedro Coelho, Peter Meinhold

Number of Employees:

51-100

Last Funding Date:

2021-10-04

IPO Status:

Private

Industries:

© 2025 bioDAO.ai